Centum Electronics Ltd Q1 FY27 Earnings Analysis

- Centum targets a medium-term revenue growth of 25% to 30% CAGR, combining both EMS and BTS segments. - BTS and EMS businesses are expected to grow at fairly similar healthy rates over time. - BTS segment order book grew at a 32% CAGR over 3 years, with standalone BTS revenue at INR 250 crores and order inflow around INR 400 crores in FY26. - A strong pipeline and secured orders support healthy growth in BTS, with significant orders expected to be booked in FY27, including spillovers. - Order inflow growth for BTS is expected to be significant in FY27, anticipating an order book growth exceeding 30%. - The INR 570 crore UHM radar order spans development and execution through FY30-FY31, adding to future revenue visibility. - Conclusive focus on standalone business after divestment of underperforming subsidiaries is expected to sustain robust growth.

- Centum targets a medium-term revenue CAGR of 25% to 30%, driven by both BTS and EMS businesses growing at healthy and similar rates. - EBITDA margin target is set between 13% to 15% over the next 1 to 2 years, with opportunities to improve further depending on business mix and operating leverage. - BTS segment has higher margin (~20% EBITDA) compared to EMS segment (~9-11% EBITDA), expected to contribute more over time. - The company expects stable or moderately increasing margin directionally within the 13%-15% band in the next 2-3 years. - Overseas subsidiaries' losses are being deconsolidated; focus shifts fully to standalone, core Indian ESDM business, which is performing well. - Profit after tax from continuing operations doubled year-on-year in FY26, indicating strong earnings momentum. - EPS growth expected to follow revenue and margin improvement aligned with the above targets and business focus.

- Centum Electronics plans capex of approximately INR 40-45 crores in the next fiscal year. - Around 50% or slightly more of this capex will be allocated to the BTS segment, focusing on R&D capabilities. - The capex is aimed at supporting growth, especially in the BTS business and enhancing product development. - No specific mention of immediate strategic investments, but emphasis on restructuring and focusing on standalone business. - Overseas subsidiaries are being deconsolidated to concentrate capital and resources on the core India business. - No expected realizations or capital gains from sale of European subsidiaries. - Investment in BTS and EMS segments continues, with capex supporting R&D and scaling operations.

- There is no explicit mention of any current or planned fundraising through debt or equity in the provided transcript. - The company maintains a comfortable debt-to-equity ratio of 0.28x as of FY26, indicating prudent financial management. - There is no discussion about raising capital via debt or equity in the Q&A or management remarks. - Focus appears to be on organic growth and optimizing existing resources, including the deconsolidation of underperforming overseas subsidiaries. - Capex guidance for FY27 is about INR 40-45 crores, indicating internal funding of growth initiatives rather than external fundraising.

- BTS segment order book as of FY26 stands close to INR 800 crores in the standalone business. - Order inflow for BTS in FY26 was around INR 466-470 crores; some orders (~INR 100-150 crores) expected to be booked in FY27, pushed from previous year. - Medium-term order book growth CAGR target is approximately 30% for BTS. - EMS order execution cycle is shorter (6-9 months), with strong visibility but order book split not directly translating to revenue split. - INR 570 crores HAL UHM radar order split into two phases: development phase (~INR 67 crores, 2 years) and execution phase (~INR 500+ crores until FY30/31). - Overall, a healthy pipeline and visibility for BTS and EMS, targeting 25-30% combined CAGR medium-term growth.